Bladder cancer in the EMPA-REG OUTCOME trial
Crossref DOI link: https://doi.org/10.1007/s00125-017-4430-0
Published Online: 2017-09-14
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kohler, Sven
Lee, Jisoo
George, Jyothis T.
Inzucchi, Silvio E.
Zinman, Bernard
Funding for this research was provided by:
The EMPA-REG OUTCOME trial was funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.
License valid from 2017-09-14